Ocuwell key facts
as of Oct 2026- Developer of ophthalmic diagnostic technology intended to improve access to advanced eye care.
- Ocuwell is valued at approximately $3.6M as of Oct 2026 (last reported valuation).
- It has raised $500K; the latest was Seed Round ($500K) in Oct 2025.
- Notable investors include Northern Gritstone, Deepbridge Capital, LYVA Labs, Sci-Tech Daresbury, The University of Liverpool.
- Status: Privately Held (backing).
Ocuwell's last reported valuation, Oct 2025. Nothing priced has surfaced since.
- ·Watch Ocuwell: the Monday email on marks, rounds and moves
Ocuwell funding rounds
No funding rounds for Ocuwell are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Ocuwell valuation
Ocuwell's last reported valuation was $3.6 million in Oct 2025. No priced round, secondary trade or fund mark has surfaced since.
Ocuwell investors
5 investors are on record for Ocuwell, including Northern Gritstone, Deepbridge Capital, LYVA Labs and Sci-Tech Daresbury.
About Ocuwell
Developer of ophthalmic diagnostic technology intended to improve access to advanced eye care. The company offers a platform featuring precision corneal topography, digital imaging, and data-driven analysis for eye health assessment, enabling ophthalmologists, optometrists, and vision care providers to deliver accurate diagnostics and early detection of corneal conditions to patients seeking accessible and reliable vision care.
- Sector
- Healthcare
- HQ
- Liverpool, United Kingdom
- Founded
- 2020
- Employees
- 10
- Website
- ocuwell.com/
- Ownership
- Privately Held (backing)
Is this your company? Profiles are maintained at PrivateMarketView, the data platform behind this page — sign in with your work email to keep it current, or tell us what's wrong.